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ABSTRACT:  Syzygium cumini seed kernel (aqueous suspension) was screened for its 
antibiadetic activity at the dose levels of 1g., 2g., 4g and 6 g/kg body weight.  4g / kg dose level 
was found to exhibit maximum hypoglycaemic effect (42.64%) in rabbits, 3hr. after medication.  
Like Tolbutamide the drug may also be promoting endogenous release of insulin.  An extra 
pancreatic site of action of the drug cannot be ruled out, since it produced a significant decrease 
in the blood sugar level (17.04%) in alloxan diabetic rats. 
 
INTRODUCTION 
 
Syzygium cumini Linn. syn. Eugenia 
jambolana  - Lam is a medicinal plant seen 
through out the plains from Himalayas to 
South India (Nadkarni, 1954).  From  very 
early days all parts of the plant viz. fruits, 
leaves, dried seeds and bark were used in 
Ayurvedic medicines for the treatment of 
several disorders (Nadkarni, 1954).   
Detailed chemical investigations have been 
made on the flowers (Sen Gupta et al. 1965; 
Nair A. G. R. et al. 1962; Sankara 
Subramoniam et al 1972; Jain et al. 1975), 
bark, (Steinmetz, 1960, Nadkarni, 1954, 
Bhargava et al. 1974) and seeds (Nadkarni 
1954, Jain et al. 1975, Steinmetz, 1960, 
Gupta  et al., 1970).  Seeds contain a 
glycoside jamboline which is responsible for 
the anti-diabetic activity (Nadkarni, 1954).   
Powdered seeds and stones of the fruit were 
used as a remedy to diabetes mellitus, since 
this was though to diminish the sugar 
content in urine and ameliorate the 
unquenchable thirst of diabetes (Nadkarni, 
1954).  The principal chemical constituents 
of the seeds of S. cumini Linn are reported to 
be jamboline, ellagic acid, tannin (19%), 
gallic acid, Chlorophyll, fatty oil, resin, 
sugar and traces of essential oil (Steinmetz, 
1960).  Therapeutic applications of the seeds 
of S. cumin  as a hypoglycaemic agent had 
been studied in some detail by several 
workers (Vaish, 1954, Aiman, 1961, Shrotri 
et. al 1963, Brahamachari et al. 1961, Renu 
Bensal et al. 1981).  In the present study the 
hypoglycaemic activity of an aqueous 
suspension of the dried seed kernels of S. 
cumini has been studied, since in Ayurveda 
the powdered seeds and stones of it were 
used as a remedy to diabetes mellitus.  Two 
standard hypoglycaemic drugs, tolbutamide 
and phenoformin were used for comparative 
study. 
 
MATERIALS AND METHODS 
 
Pharmacognostically identified sample of 
the seeds of S. cumini was provided from the 
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Kerala.  The dried seed kernels were 
powered and used as an aqueous suspension 
in water. 
 
Hypoglycaemic activity 
 
Adult male rabbits (1 to 1.5 kg) fasted 
overnight were divided into six groups, each 
containing six animals.  Before the start of 
the experiment, fasting blood was collected 
from all the animals.  First group of animals 
given distilled water through oral 
intubations served as control whereas 
Tolbutamide (250 mg /kg) and Phenforminc 
(20 mg/kg) administered to second and third 
group of animals served as reference 
standards.  Groups IV to VII were given 
orally an aqueous suspension of dried seed 
kernel of S. cumini at dose levels 1 g., 2g., 
4g. and 6g/kg body weight respectively.  A 
fluid volume of 10ml / kg was maintained 
constant for all the animals at intervals of 
1hr., 3hr. and 5hr and blood sugar was 
estimated (Asatoor et al 1954). 
 
Glucose tolerance in rabbits 
 
From the above studies it was found that 4g. 
/ kg dose of seed kernel of S. cumini 
exhibited maximum hypoglycaemic activity.  
Glucose tolerance study was made with this 
effective dose of 4g / kg body weight.  Adult 
male rabbits (1 to 1.5 kg) were fasted 
overnight and divided into 4 groups.  Fasting 
blood was collected from each animal and 
blood sugar estimated (Asatoor et. al 1954).  
Control rabbits were given distilled water.   
Tolbutamide (250 mg/ kg) and Phenoformin 
(20 mg/kg) were administrated to second 
and third groups of rabbits while aqueous 
suspension of seed kernel of S. cumini 
(4g/kg) was given to fourth groups of 
animals.   One hour after drug 
administration, blood samples were 
collected and glucose (1 g / kg) was 
administered orally to all rabbits.  There 
after blood was collected from all the 
animals at intervals of 30 minutes up to 3 
hrs. and blood sugar was estimated. 
 
Effect on Alloxan Diabetic Rats 
 
Male albino rats (150 to 180 g. body weight) 
were made diabetic by a single rapid i.p. 
injection of 120 mg/kg of alloxan 
monohydrate (5% W/v in water) and used 
after 3 days by selecting on the basis of 
blood sugar levels.  The diabetic animals 
which have about three times the initial 
blood  sugar levels were then divided into 
three groups, each containing 5 number of 
animals.  Control rats were given orally 
distilled water.  Tolbutamide (250 mg/kg) 
and Phenformina (20 mg/kg) were given to a 
second and third groups while aqueous 
suspension of S. cumini seed kernel (4g/kg) 
were given to a fourth group of gavages.   
Blood was collected from all the animals at 
intervals of 1 hr., 3 hr. and 5 hr. and blood 
sugar was estimated (Asatoor et. al. 1954). 
 
RESULTS AND DISCUSSION 
 
The blood sugar changes in rabbits 
administered different doses of aqueous 
suspension of dried seed kernels viz., 1g., 
2g., 4g. and 6 g/kg body weight indicate that 
the optimum dose level is     4 g/kg (Table 
I).  The maximum reduction in blood sugar 
was noted for all the dose levels at the third 
hour after administration of the drug.  The 
reduction was maximum for the 4 g/ kg 
body weight dose level being 42.64% as 
compared to the other dosages (1 g/kg body 
weight  –  6.9%, 2 g/kg body weight – 
26.12%, 6 g/kg body weight – 14.4%).  The 
percentage reduction in blood sugar brought 
about by Tolbutamide (250 mg/kg) at the 
third hour after medication was 52.10% and 
that of Phenformin 25%.  The results show 
that the drugs at all dose levels does not 
have prolonged hypoglycaemic actions as Pages 80 - 84 
compared to the standard anti diabetic drugs.  
Tolbutamide whose hypoglycaemic effect is 
evident from 1hr, after medication and is 
persisting even after 5
th  hr. of 
administration.  Phenformin has prolonged 
hypoglycaemic action (34.3%) even after 5
th 
hr. of medication. 
 
In the alloxan diabetic rats Tolbutamide 
(250 mg/kg) did not exhibit significant 
hypoglycaemic effect whereas Phenformin 
(20 mg/kg) showed considerable 
hypoglycaemic effect (Table 2).  Alloxan 
administration has been reported to damage 
B-cells of Langerhans from where insulin is 
released.  Tolbutamide cannot exert any 
hypoglycaemic effect in the alloxan diabetic 
rats as it does in the normal rats where it 
greatly enhances insulin release (Jenkins et 
al. 1978).  However the drug could produce 
hypoglycaemic effect (17.04%) in the 
alloxan diabetic rats at the third hour after 
medication (Table. II). 
 
TABLE – I 
 
Pattern of blood sugar on administration of S. cumini to normal Rabbits 
 
Drug treated dose / kg 
(oral) 
Blood sugar in mg / 100 ml ± S. E. of six animals 
  Fasting  1 hr.  3 hr.  5 hr 
Control  (Dist. Water) 
 
Tolbutamide (250 mg) 
 
Phenformin (20 mg) 
 
S. cumini Seed – Kernel 
(Aq. Susp.) 
 
1g. 
 
2g. 
 
4g. 
 
6g. 
 
 
99.7 ± 8.6 
 
97.3 ± 7.3 
 
97.1 ± 1.0 
 
 
 
 
98.6 ± 3.4 
 
102.0 ± 5.6 
 
109.4 ± 4.4 
 
96.1 ± 4.1 
96.2 ± 7.5 
 
61.9 ± 5.1
b 
 
87.2 ± 3.2
a 
 
 
 
 
97.6 ± 4.1 
 
89.1 ± 5.7 
 
90.0 ± 3.4
b 
 
92.7 ± 3.0 
92.1 ± 5.4 
 
46.9 ± 5.6
c 
 
73.8 ± 3.4
c 
 
 
 
 
91.8 ± 3.7 
 
75.4 ± 3.7
b 
 
62.7 ± 2.3
c 
 
82.2 ± 1.8
a 
95.8 ± 8.0 
 
45.3  ± 5.4
c 
 
63.8 ± 2.3
c 
 
 
 
 
93.9 ± 1.6 
 
73.3 ± 4.1
b 
 
72.7 ± 3.5
c 
 
90.0 ± 3.0 
 
 
 
P Values, a<0.05, b<0.01, C< 0.001
   Pages 80 - 84 
TABLE – II 
 
Pattern of blood sugar on treatment with S. cumini in diabetic rats 
 
Drug treated dose / kg 
(oral) 
Blood sugar in mg / 100 ml ± S. E. of five animals 
  Fasting  1 hr.  3 hr.  5 hr 
Control  (Dist. Water) 
 
Tolbutamide (250 mg) 
 
Phenformin (20 mg) 
 
S. cumini Seed – Kernel 
(Aq. Susp.) 
 
 
4g. 
 
 
305.3 ± 8.7 
 
283.5 ± 7.4 
 
197.7 ± 4.9 
 
 
 
 
 
290.3 ± 11.4 
 
 
301.4 ± 5.2 
 
274.4 ± 5.8 
 
133.8 ± 10.1
c 
 
 
 
 
 
273.2 ± 14.0 
 
 
298.1 ± 7.1 
 
271.9 ± 7.4 
 
107.9 ± 2.2
c 
 
 
 
 
 
240.8 ± 6.5
a 
 
 
297.1 ± 8.5 
 
270.2± 9.1 
 
94.4 ± 5.3
c 
 
 
 
 
 
252.8 ± 8.1
a 
 
 
 
P Values, a<0.05, C< 0.001 
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The glucose tolerance curve of rabbits 
administered the drug (4g/kg body weight), 
Tolbutamide (250 mg/kg) and Phenformin 
(20mg/kg) is presented in figure.1 
Tolbutamide and Phenformin reduced blood 
sugar values to the fasting level between 2 
and 2 ½ hrs. after medication.  The effect of 
the drug is well comparable to that of 
Tolbutamide and Phenformin as it brings 
down the blood sugar to the baseline 
between 1 ½ -  2 hrs.  The initial rise in 
blood sugar was observed in the drug treated 
and Tolbutamide and Phenformin treated 
rabbits 30 minutes after administration of 
glucose.  However in the control animals the 
initial rise in blood sugar after glucose 
administration is very high (Fig. 1).  This 
suggests that like Tolbutamide the drug may 
also be promoting endogenous release of 
insulin. Tolbutamide is inactive in alloxan 
diabetic animals.  It inhibits glutamine 
Fructose – 6 – phosphate aminotransferase 
and thus reduces the synthesis of 
glucosamine  –  6  –  phosphate and finally 
glucose.  Gluconeogenesis is reduced and 
hence the hypoglycaemic effect.   
Phenformin increases glucose uptake by 
peripheral tissues and accelerates anaerobic 
glycolysis because of an uncoupling effect 
of oxidative phosphoryation. 
 
The fact that the seed kernels of S. cumini 
produced a significant decrease in the sugar 
level of alloxan induced rats indicates an 
extra pancreatic site of action for the drug, 
probably by acting on the  glycogen 
biosynthetic and degradative pathways.  The 
seed kernel was found to exert maximum 
hypoglycaemic effect unlike the whole seeds 
which had been reported to produce 
maximum effect in four to five hours after 
medication (Shrotri et al. 1963).  It is 
possible that the tannins, phytosteroleins etc. 
(Rajarama Rao et al.  1966) present in the 
whole seeds may inhibit the absorption of 
the active principle from the gastrointestinal 
tract thereby retarding the effect. 
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